Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®
NCT03445637
·
clinicaltrials.gov ↗
COMPLETED
Status
552
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Neoplasm
Sponsor
Pfizer